New hope for rare aHUS: experimental drug aims to stop blood clots
NCT ID NCT05684159
First seen Apr 16, 2026 · Last updated May 21, 2026 · Updated 6 times
Summary
This study tests a new medicine called NM8074 in 12 adults with a rare disease called atypical hemolytic uremic syndrome (aHUS). The goal is to see if the drug can stop abnormal blood clotting and improve kidney function. Participants will receive the drug through a vein, and researchers will monitor blood counts and kidney health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AHUS - ATYPICAL HEMOLYTIC UREMIC SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.